Seeing Is Believing
Currently out of the existing stock ratings of Tom Roderick, 192 are a BUY (72.73%), 69 are a HOLD (26.14%), 3 are a SELL (1.14%).
Analyst Tom Roderick, currently employed at STIFEL, carries an average stock price target met ratio of 87.21% that have a potential upside of 18.67% achieved within 149 days.
Tom Roderick’s has documented 426 price targets and ratings displayed on 26 stocks. The coverage is on Technology, Healthcare sectors.
Most recent stock forecast was given on DOX, Amdocs Ltd at 02-Oct-2024.
Analyst best performing recommendations are on MDLA (MEDALLIA).
The best stock recommendation documented was for MDLA (MEDALLIA) at 7/22/2019. The price target of $43 was fulfilled within 4 days with a profit of $7 (19.44%) receiving and performance score of 48.61.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$510
$161.2 (46.22%)
$600
9 days ago
(16-Apr-2025)
24/35 (68.57%)
$165.81 (48.17%)
107
Buy
$450
$101.2 (29.01%)
$495
9 days ago
(16-Apr-2025)
29/42 (69.05%)
$105.81 (30.74%)
123
Buy
$450
$101.2 (29.01%)
$625
11 days ago
(14-Apr-2025)
3/8 (37.5%)
$99.09 (28.24%)
30
Buy
$480
$131.2 (37.61%)
$590
11 days ago
(14-Apr-2025)
5/14 (35.71%)
$129.09 (36.79%)
271
Hold
$380
$31.2 (8.94%)
$460
14 days ago
(11-Apr-2025)
11/17 (64.71%)
$27.53 (7.81%)
103
What Year was the first public recommendation made by Tom Roderick?